The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity

Yangchun Xie,Shan Zhu,Xinxin Song,Xiaofang Sun,Yong Fan,Jinbao Liu,Meizuo Zhong,Hua Yuan,Lin Zhang,Timothy R Billiar,Michael T Lotze,Herbert J Zeh 3rd,Rui Kang,Guido Kroemer,Daolin Tang

DOI: https://doi.org/10.1016/j.celrep.2017.07.055

2017-08-15

Abstract:Ferroptosis is a form of regulated cell death that may facilitate the selective elimination of tumor cells. The tumor suppressor p53 (TP53) has been demonstrated to promote ferroptosis via a transcription-dependent mechanism. Here, we show that TP53 limits erastin-induced ferroptosis by blocking dipeptidyl-peptidase-4 (DPP4) activity in a transcription-independent manner. Loss of TP53 prevents nuclear accumulation of DPP4 and thus facilitates plasma-membrane-associated DPP4-dependent lipid peroxidation, which finally results in ferroptosis. These findings reveal a direct molecular link between TP53 and DPP4 in the control of lipid metabolism and may provide a precision medicine strategy for the treatment of colorectal cancer by induction of ferroptosis.